TP53 and hepatocellular carcinoma: In multivariate COX regression analysis, we found that TP53 mutations, LRP1B mutations, and serum abnormal prothrombin II (PIVKA-II) levels were independent factors of recurrence in HCC patients with TNMI and TNMII within one year (Figure 2E).